Literature DB >> 21577008

Maternal immune activation impairs reversal learning and increases serum tumor necrosis factor-α in offspring.

Xiao Han1, Nanxin Li, Qingxuan Meng, Feng Shao, Weiwen Wang.   

Abstract

Maternal immune activation (MIA) produces a variety of behavioral and brain abnormalities in rodent models of several neuropsychiatric disorders. However, it remains controversial whether MIA impairs reversal learning, a basic function of flexibility relevant to those diseases, in offspring. In the present study, we used the Morris water maze to investigate the effects of middle to late gestation stage poly(I:C) challenges on spatial learning and subsequent reversal learning performance in adolescent rats. Maternal poly(I:C) treatment induced deficits in reversal learning without affecting spatial acquisition abilities. In addition, the serum level of the proinflammatory cytokine tumor necrosis factor-α was increased in MIA rats. This study advances our understanding of how MIA affects adolescent behavior and brain function.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21577008     DOI: 10.1159/000322455

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  10 in total

Review 1.  Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia.

Authors:  Anna M Fineberg; Lauren M Ellman
Journal:  Biol Psychiatry       Date:  2013-02-12       Impact factor: 13.382

2.  Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation.

Authors:  Sarah C Konefal; David Stellwagen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-03-05       Impact factor: 6.237

3.  Long-term altered immune responses following fetal priming in a non-human primate model of maternal immune activation.

Authors:  Destanie R Rose; Milo Careaga; Judy Van de Water; Kim McAllister; Melissa D Bauman; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2016-11-19       Impact factor: 7.217

Review 4.  Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors:  Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal:  ACS Pharmacol Transl Sci       Date:  2020-10-28

Review 5.  Maternal Immune Activation and Autism Spectrum Disorder: From Rodents to Nonhuman and Human Primates.

Authors:  Milo Careaga; Takeshi Murai; Melissa D Bauman
Journal:  Biol Psychiatry       Date:  2016-10-25       Impact factor: 13.382

6.  Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul S Horn; Brad Chambers; Jon Davis; Stephen Benoit
Journal:  Psychopharmacology (Berl)       Date:  2012-07       Impact factor: 4.530

7.  Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders.

Authors:  Stephanie A Ballendine; Quentin Greba; Wojciech Dawicki; Xiaobei Zhang; John R Gordon; John G Howland
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-12       Impact factor: 5.067

8.  Neonatal infection modulates behavioral flexibility and hippocampal activation on a Morris Water Maze task.

Authors:  Lauren L Williamson; Staci D Bilbo
Journal:  Physiol Behav       Date:  2014-02-24

Review 9.  The immune system and developmental programming of brain and behavior.

Authors:  Staci D Bilbo; Jaclyn M Schwarz
Journal:  Front Neuroendocrinol       Date:  2012-09-09       Impact factor: 8.606

10.  Gestational cytokine concentrations and neurocognitive development at 7 years.

Authors:  Akhgar Ghassabian; Paul S Albert; Mady Hornig; Edwina Yeung; Sara Cherkerzian; Risë B Goldstein; Stephen L Buka; Jill M Goldstein; Stephen E Gilman
Journal:  Transl Psychiatry       Date:  2018-03-13       Impact factor: 6.222

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.